AtriCure (ATRC) Non Operating Interest Expenses (2010 - 2026)

AtriCure (ATRC) has reported Non Operating Interest Expenses for 17 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 11.54% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 6.54% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 8.26% from the prior year.
• Non Operating Interest Expenses was $1.3 million for Q2 2026 at AtriCure, down from $1.3 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $1.8 million in Q4 2023 and troughed at $1.0 million in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.5 million in 2025 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses surged 63.6% in 2023 and decreased 19.3% in 2024, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $1.6 million in 2022, then increased by 15.18% to $1.8 million in 2023, then declined by 19.3% to $1.5 million in 2024, then rose by 3.65% to $1.5 million in 2025, then declined by 12.37% to $1.3 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $1.3 million (Q2 2026), $1.3 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.